Presentation Pattern of Lower Extremity Endovascular Intervention versus Percutaneous Coronary Intervention.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Aug 2020
Historique:
pubmed: 22 11 2019
medline: 5 6 2021
entrez: 22 11 2019
Statut: ppublish

Résumé

The aim of the current study is to describe the presentation pattern of symptomatic peripheral artery disease undergoing endovascular therapy (EVT) in comparison to symptomatic coronary artery disease undergoing percutaneous coronary intervention (PCI) based on data from nationwide databases. Data were extracted from the nationwide procedural databases of EVT and PCI in Japan (J-EVT and J-PCI) between 2012 and 2017. The presentation pattern was investigated using a Poisson regression model, including the month, seasonality, and weekend (versus weekday) as the explanatory variables. Seasonality was expressed as a cosine function of a 12-month period, and its significance was evaluated using the Fisher-Yates shuffle method. A total of 41,906 and 62,585 cases underwent EVT for critical limb ischemia (CLI) and intermittent claudication (IC), respectively, whereas 518,858 and 504,139 cases underwent PCI for acute coronary syndrome (ACS) and stable angina (SA). The procedural volume increased by 21.6%, 12.3%, 4.5%, and 3.6% per year in CLI, IC, ACS, and SA. CLI and ACS, but not IC or SA, showed a significant volume seasonality. Compared with ACS, CLI demonstrated a larger peak-to-trough ratio of seasonality (1.75 versus 1.21; P<0.001), and a later peak appearance (February-March versus January-February by 1.37 months; P<0.001). The procedural volume on weekends relative to weekdays was smaller for SA, IC, and CLI than for ACS. These distinct features were observed in a diabetic population and a non-diabetic population. The current study analyzed nationwide procedural databases and demonstrated the presentation pattern of symptomatic PAD and CAD warranting revascularization.

Identifiants

pubmed: 31748468
doi: 10.5551/jat.53330
pmc: PMC7458786
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

761-768

Références

Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75
pubmed: 17140820
Lancet. 1971 Jan 9;1(7689):83
pubmed: 4099246
Diabetol Int. 2019 Jun 17;11(1):33-40
pubmed: 31950002
Cardiovasc Interv Ther. 2018 Oct;33(4):297-312
pubmed: 29654408
PLoS One. 2012;7(3):e32478
pubmed: 22427844
J Atheroscler Thromb. 2019 Mar 1;26(3):294-301
pubmed: 30135330
Am J Cardiol. 2008 Nov 15;102(10):1307-11
pubmed: 18993146
J Atheroscler Thromb. 2013;20(9):726-32
pubmed: 23739660
J Atheroscler Thromb. 2019 Apr 1;26(4):351-361
pubmed: 30249941
JAMA. 2001 Sep 19;286(11):1317-24
pubmed: 11560536
Br J Clin Pharmacol. 2001 Jul;52(1):17-23
pubmed: 11453886
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
Cardiovasc Diabetol. 2017 Apr 4;16(1):41
pubmed: 28376797
J Am Coll Cardiol. 2017 Mar 21;69(11):e71-e126
pubmed: 27851992
Diabetol Int. 2018 Dec 8;10(3):231-235
pubmed: 31275791
Cardiovasc Interv Ther. 2018 Apr;33(2):178-203
pubmed: 29594964
J Rheumatol. 1999 Aug;26(8):1734-7
pubmed: 10451070
Can J Cardiol. 2009 Jan;25(1):39-45
pubmed: 19148341
J Atheroscler Thromb. 2018 Sep 1;25(9):808-820
pubmed: 29540636
Eur Heart J. 2015 Apr 14;36(15):932-8
pubmed: 25650396
J Atheroscler Thromb. 2020 Feb 1;27(2):134-143
pubmed: 31217396

Auteurs

Mitsuyoshi Takahara (M)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine.
Department of Health Quality Assessment, The University of Tokyo.

Osamu Iida (O)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Cardiovascular Center, Kansai Rosai Hospital.

Shun Kohsaka (S)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Department of Cardiology, Keio University School of Medicine.

Yoshimitsu Soga (Y)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Department of Cardiology, Kokura Memorial Hospital.

Masahiko Fujihara (M)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Department of Cardiology, Kishiwada Tokushukai Hospital.

Toshiro Shinke (T)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Division of Cardiovascular Medicine, Department of Internal Medicine, Showa University School of Medicine.

Tetsuya Amano (T)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Department of Cardiology, Aichi Medical University.

Yuji Ikari (Y)

The Japanese Association of Cardiovascular Intervention and Therapeutics.
Department of Cardiology, Tokai University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH